Submitted by pharmacytimescom9583 in news
The approval marks the first monoclonal antibody approved to protect all infants through their first respiratory syncytial virus season.
Submitted by pharmacytimescom9583 in news
The approval marks the first monoclonal antibody approved to protect all infants through their first respiratory syncytial virus season.